NCT03221491

Comparison of Patient-Controlled Analgesia With Different Background Infusion

Completed NA Last updated 21 July 2017

What this trial tests

NA trial testing Patient-Controlled Analgesia(PCA) in Patient-Controlled Analgesia in 90 participants. Completed in 30 June 2017.

Timeline

1 July 2016

Primary endpoint
30 June 2017

30 June 2017

Quick facts

Lead sponsor	Weifeng Tu
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	health services research
Enrollment	90
Start date	1 July 2016
Primary completion	30 June 2017
Estimated completion	30 June 2017
Sites	1 location across China

Drugs / interventions tested

• Patient-Controlled Analgesia(PCA)

Conditions studied

• Patient-Controlled Analgesia — all drugs for Patient-Controlled Analgesia →

Sponsor

Weifeng Tu — full company profile →

Who can join

Adults 18 to 65, any sex, with Patient-Controlled Analgesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, the investigators investigated the efficacy, usefulness and analgesic consumption of three different patient-controlled analgesia(PCA) programmes:bolus dose alone without background infusion, bolus dose with low background infusion and bolus dose with high background infusion to evaluate postoperative analgesia for patients after laparoscopic colorectal surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.